Lipella Pharmaceuticals Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
LIPO Company Description
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
LIPO Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view LIPO Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of LIPO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by LIPO's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of LIPO in WallStreetBets Daily Discussion
LIPO News
Recent insights relating to LIPO
CNBC Recommendations
Recent picks made for LIPO stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in LIPO
Corporate Flights
Flights by private jets registered to LIPO
Our Analysis